Fig. 2

Scatter plots representing pre- and post- chemotherapy plasma levels of EpCAM+ EVs (a-c), CD45+ EVs (d-f) and double positive EPCAM+CD45+ EVs (g-i) in platinum-sensitive (n=17), -resistant (n=6) and -refractory patients (n=5). a-c Pre- and post-chemotherapy plasma levels of EpCAM+ EVs across patients’ groups. d-f Pre- and post-chemotherapy plasma levels of CD45+ EVs across patients’ groups. g-i Pre- and post-chemotherapy plasma levels of double positive EpCAM+CD45+ EVs across patients’ groups. Results are expressed as mean +/- SD or median, according to type of variables. Pre: pre-chemotherapy; Post: post chemotherapy; ns: not significant; * p<0.05; **p<0.01